METHOD FOR PRODUCING OPTICALLY ACTIVE ENANTIOMERS OF PIRLINDOLE AND ITS SALTS Russian patent published in 2018 - IPC C07D487/06 A61K31/495 

Abstract RU 2666731 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a novel process for the preparation of optically active enantiomers of pirlindole selected from the group consisting of enantiomerically pure (S)-pirlindole and (R)-pirlindole, in free base form or in the form of a pharmaceutically acceptable salt, characterized in that separation by crystallization with optically active acids (rac)-pirlindole in the form of a free base is carried out, wherein the optically active acids are selected from the group consisting of: (R)-mandelic acid, (R)-(+)-α-methoxy-α-trifluoromethylphenylacetic acid and (S)-mandelic acid.

EFFECT: new method for the preparation of optically active enantiomers of pyrrolindole, which is a reversible inhibitor of monoamine oxidase A, can be used to treat depression.

14 cl, 12 ex

Similar patents RU2666731C2

Title Year Author Number
PHARMACEUTICALLY ACCEPTABLE SALTS OF PYRILINDOLE ENANTIOMERS FOR USE IN MEDICINE 2014
  • Pardal Filipe, Augusto Eugenio
  • Eufrasio Pedroso, Pedro Filipe
  • Almeida Pecorelli, Susana Marques
  • Casimiro Caixado, Carlos Alberto Eufrasio
  • Lopes, Ana Sofia Da Conceicao
  • Damil, Joao Carlos Ramos
  • E Oliveira Santos, Pedro Paulo De Lacerda
RU2706688C2
(S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE 2014
  • Pardal Filipe, Augusto Eugenio
  • Eufrasio Pedroso, Pedro Filipe
  • Almeida Pecorelli, Susana Marques
  • Casimiro Caixado, Carlos Alberto Eufrasio
  • Lopes, Ana Sofia Da Conceicao
  • Damil, Joao Carlos
RU2695647C2
(R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE 2014
  • Pardal Filipi Augushtu Euzheniu
  • Eufraziu Pedrozu Pedru Filipi
  • Almejda Pekorelli Suzana Markesh
  • Kazimiru Kaishadu Karlosh Albertu
  • Lopesh Ana Sofiya Da Konsejsau
  • Damil Zhoan Karlosh Ramosh
RU2695607C2
AMINO ACID ESTERS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING 1998
  • Merpul Liven
  • Kheres Jan
  • Khendriks Robert Jozef Marija
RU2197489C2
METHOD OF PREPARING ENANTIOMERICALLY PURE IMIDAZOLYL COMPOUNDS, ENANTIOMERICALLY PURE ACID ADDITION SALT OF IMIDAZOLYL AND D-OR L-PYROGLUTAMIC ACID, AND HYDROCHLORIDE MONOHYDRATE OF ENANTIOMERICALLY PURE IMIDAZOLYL COMPOUNDS 1996
  • Pauljus Fransiskus Kornelis Van Der Mej
  • Jan-Marten Verbek
RU2162085C2
METHOD FOR PRODUCTION OF AMLODIPINE ENANTIOMER OF HIGH OPTIC PURITY 2005
  • Gkharpure Milind Moreshvar
  • Bkhaval Baburao Manikrao
  • Ranade Prasad Vasudeo
  • Deshm'Uk Radzhendra Dagadu
  • Mekhta Satish Ramanlal
RU2376288C2
METHOD OF RACEMIZATION OF OPTICALLY PURE OR ENRICHED PIPERAZIN-2-TERT-BUTYLCARBOXAMIDE SUBSTRATE AND RACEMIC 2-TERT-BUTYLCARBOXAMIDE-4-(3-PICOLYL)PIPERAZINE 1995
  • Kaj Rossen
  • Dehvid Askin
  • Pol Rejder
  • Richard Dzh.Varsolona
  • Ral'F Volante
RU2135482C1
OPTICALLY PURE Na, Mg, Li, K OR Ca SALTS OF (-)-5-METHOXY-2-[[(4- -METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZ-IMIDAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID AND INTERMEDIATE COMPOUND 1994
  • Per Lennart Lindberg
  • Sverker Von Unge
RU2137766C1
DIMETHYLBENZOFURANS AND DIMETHYLBENZOPYRANES, THEIR USE AS 5-HT-ANTAGONISTS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION 1993
  • Zhorzh-Anri Pol' Van Dael'
  • Zhan-Pol' Rene Mari Andre Bosman
  • Uilli Dzhouns Karolus Van Laerovan
RU2116072C1
COMPOSITIONS AND METHODS OF USING (R)-PRAMIPEXOLE 2007
  • Petsinger Tomas Ml.
  • Gribkoff Valentin
  • Bozik Majkl E.
RU2491068C2

RU 2 666 731 C2

Authors

Pardal Filipe, Augusto Eugenio

Eufrasio Pedroso, Pedro Filipe

Almeida Pecorelli, Susana Marques

Casimiro Caixado, Carlos Alberto Eufrasio

Lopes, Ana Sofia Da Conceicao

Damil, Joao Carlos Ramos

E Oliveira Santos, Pedro Paulo De Lacerda

Dates

2018-09-12Published

2014-05-09Filed